Maxime Dely: Platelet Agitation Strengthens Quality and Confidence in Transfusion Medicine
Maxime Dely, Sales and Application Specialist in Therapeutic Apheresis and Cell Therapy, shared a post on LinkedIn:
”Platelet concentrate agitation: a technical detail that saves lives
In transfusion medicine, clinical performance begins long before administration. It starts with storage conditions.
Platelet concentrates are stored at 20–24°C under continuous agitation. This is not a logistical choice, but a physiological one. Platelets are living, metabolically active cells: they consume oxygen, produce CO₂, and generate metabolites.
Without agitation, gas exchange decreases, pH drops, metabolism is altered, and hemostatic function deteriorates. Ultimately, this affects cell viability and transfusion efficacy.
Gentle, continuous agitation optimizes oxygenation, limits CO₂ accumulation, and helps maintain biochemical parameters compatible with optimal platelet function.
This measure directly contributes to risk control, both infectious and functional, and therefore to patient safety.
In transfusion medicine, scientific rigor is never optional. Every controlled parameter strengthens quality, safety, and confidence in the transfusion process.
Because behind every platelet concentrate, there is a patient who matters.”
Patricia Epstein, Head of the Hemotherapy Division at Hospital Gral de Agudos “Dr. Carlos G. Durand” and Head of Service at Hospital General de Agudos Juan A. Fernandez, shared this post, adding:
”All points of the process make up the final product, as in any production line….. details matter!!!”
Proceed to the video attached to the post.
Find more posts featuring Maxime Dely on Hemostasis Today.
-
Feb 20, 2026, 14:26Wolfgang Miesbach: Individualized Hemostasis Care for Gender-Diverse Patients
-
Feb 20, 2026, 14:20Yves Bikorimana: Before Wash vs After Wash in Blood Grouping
-
Feb 20, 2026, 14:17Building Long-Term Hemophilia Care in Kyrgyzstan Beyond Treatment – WFH
-
Feb 20, 2026, 13:45Danny Hsu: Can We Prevent VTE Without Increasing Bleeding Risk?
-
Feb 20, 2026, 10:26Eithne Sexton: Our Interactive Dashboards for Future Stroke Projections at SPHeRE Conference
-
Feb 20, 2026, 10:06Rémi Bonjean: The 1st VHHs Against Active Rap1 to Monitor Platelet Activation
-
Feb 20, 2026, 09:50Latifa Alhassan: HIV Is a Danger Looming For Our Unborn Children and For The Economy of Ghana
-
Feb 20, 2026, 09:35Gregory Makris: Factor XI Makes the Leap from OCEANIC Stroke to the ESO 2025 Update
-
Feb 20, 2026, 09:27Waseem Mujahed: Compartment Syndrome as the Initial Presentation of Postpartum Acquired Hemophilia